Current Affairs

Cancer Drug Price Caps

2.3 Social Justice, The Hindu, 2026-11-06

The National Pharmaceutical Pricing Authority (NPPA) capped trade margins at 30% for 137 non-scheduled anti-cancer drugs, cutting prices of nearly 900 brands by up to 70%-93%. Of 1,024 brands analysed, 45.4% saw cuts above 50% and 194 brands saw no reduction, priced from over ₹1 lakh to ₹10 lakh. Median cancer treatment expenditure is about ₹4.1 lakh, with 80% paid out of pocket. A 2022 Parliamentary Standing Committee on Health report noted nearly 40% of patients borrow or pledge assets.